Adipokine Modulation in Type 2 Diabetes Pathophysiology
Summary
Adipose tissue functions as a dynamic endocrine organ, secreting a spectrum of bioactive peptides and proteins—collectively termed adipokines—that orchestrate systemic energy homeostasis, appetite, insulin sensitivity and inflammatory tone. In type 2 diabetes, hypertrophic expansion of visceral fat depots shifts the balance towards proinflammatory adipokines such as tumour necrosis factor-α and adipocyte fatty acid-binding protein, while levels of insulin-sensitising, anti-inflammatory mediators such as adiponectin decline. This dysregulated secretory profile drives peripheral insulin resistance, β-cell stress and endothelial dysfunction, thus linking metabolic derangement to vascular complications. Modulating adipokine production, receptor signalling or downstream pathways has emerged as a promising strategy to restore glycaemic control, ameliorate chronic inflammation and reduce cardiovascular risk. Advances in lipidomic analyses and clinical trials of insulin sensitizers further illuminate how pharmacological agents remodel adipose biology to counteract the pathophysiological cascade of type 2 diabetes.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Adipokine Modulation in Type 2 Diabetes Pathophysiology publication trend
The graph below shows the total number of articles in adipokine modulation in type 2 diabetes pathophysiology across all publications each year (not limited to Nature Index journals).
Technical terms
Adipokine: A hormone-like molecule secreted by adipose tissue that regulates metabolism, inflammation and vascular function.
Insulin resistance: A state in which peripheral tissues respond inadequately to normal insulin levels, leading to impaired glucose uptake and hyperglycaemia.
Adipogenesis: The process by which preadipocytes differentiate into mature adipocytes, contributing to the expansion of adipose tissue.
Peroxisome proliferator-activated receptor γ (PPARγ): A nuclear receptor that regulates genes involved in adipocyte differentiation, lipid metabolism and insulin sensitivity.
References
- Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity. Journal of Diabetes Research (2017).
- The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans. Frontiers in Physiology (2021).
- A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus. The Egyptian Journal of Internal Medicine (2024).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.